These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2654356)

  • 1. Furosemide pharmacokinetics and pharmacodynamics in health and disease--an update.
    Hammarlund-Udenaes M; Benet LZ
    J Pharmacokinet Biopharm; 1989 Feb; 17(1):1-46. PubMed ID: 2654356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers.
    Lesne M
    Arzneimittelforschung; 1988 Jan; 38(1A):160-3. PubMed ID: 3370062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
    Vargo DL; Kramer WG; Black PK; Smith WB; Serpas T; Brater DC
    Clin Pharmacol Ther; 1995 Jun; 57(6):601-9. PubMed ID: 7781259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of meloxicam on furosemide pharmacokinetics and pharmacodynamics in healthy volunteers.
    Müller FO; Schall R; de Vaal AC; Groenewoud G; Hundt HK; Middle MV
    Eur J Clin Pharmacol; 1995; 48(3-4):247-51. PubMed ID: 7589049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics/pharmacodynamics of furosemide in man: a review.
    Benet LZ
    J Pharmacokinet Biopharm; 1979 Feb; 7(1):1-27. PubMed ID: 458552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteers.
    Klausner EA; Lavy E; Stepensky D; Cserepes E; Barta M; Friedman M; Hoffman A
    J Clin Pharmacol; 2003 Jul; 43(7):711-20. PubMed ID: 12856384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Localization of the action of furosemide and triamterene in the nephron by means of correlating their pharmacokinetics and pharmacodynamics].
    Lebedev AA; Munina II
    Farmakol Toksikol; 1989; 52(1):44-7. PubMed ID: 2707420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pharmacodynamics and pharmacokinetics of furosemide during ordinary life activities and during head-down tilt hypokinesia in a healthy subject].
    Noskov VB; Goncharov IV; Kovachevich IV; Repenkova LG; Kodratenko SN; Starodubtsev AK
    Eksp Klin Farmakol; 1998; 61(4):29-33. PubMed ID: 9783105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of long-acting furosemide and instant-acting amiloride: pharmacokinetics and pharmacodynamics in human subjects.
    Flouvat B; Roux A; Leneveu A; Prinseau J; Alexandre JA
    Fundam Clin Pharmacol; 1991; 5(8):741-52. PubMed ID: 1783363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics and pharmacodynamics of furosemide in the anaesthetized dog.
    Hirai J; Miyazaki H; Taneike T
    J Vet Pharmacol Ther; 1992 Sep; 15(3):231-9. PubMed ID: 1433485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites.
    Gentilini P; La Villa G; Marra F; Carloni V; Melani L; Foschi M; Cotrozzi G; Quartini M; Chibbaro G; Tommasi AC; Bernareggi A; Simoni A; Buzzelli G; Laffi G
    J Hepatol; 1996 Oct; 25(4):481-90. PubMed ID: 8912147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics and pharmacokinetics of furosemide-retard and furosemide-retard/triamterene.
    Heimsoth V; Loew D; Schuster O
    Eur J Drug Metab Pharmacokinet; 1988; 13(3):161-4. PubMed ID: 3240762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of Urinary Output Response to IV Furosemide in Acute Kidney Injury: A Pharmacokinetic/Pharmacodynamic Study.
    Silbert BI; Ho KM; Lipman J; Roberts JA; Corcoran TB; Morgan DJ; Pavey W; Mas E; Barden AE; Mori TA
    Crit Care Med; 2016 Oct; 44(10):e923-9. PubMed ID: 27183025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of high dose furosemide in patients with chronic renal failure or nephrotic syndrome.
    Kühnel HJ; Günther K; Stein G; Hoffmann-Traeger A
    Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):616-21. PubMed ID: 3429064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).
    Ponto LL; Schoenwald RD
    Clin Pharmacokinet; 1990 Jun; 18(6):460-71. PubMed ID: 2191821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics and pharmacodynamics of furosemide in liver cirrhosis].
    Tesar V; Kotal P; Petrtýl J; Bukovská J; Kozáková M; Brodanová M; Horký K; Kordac V
    Cas Lek Cesk; 1990 May; 129(21):657-64. PubMed ID: 2369756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diuretic effect and disposition of furosemide in cystic fibrosis.
    Prandota J; Smith IJ; Hilman BC; Wilson JT
    Eur J Clin Pharmacol; 1991; 40(4):333-41. PubMed ID: 2050167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diuretic effect of furosemide in relation to its disposition in man.
    Zhu JB; Koizumi T
    J Pharmacobiodyn; 1987 Aug; 10(8):377-83. PubMed ID: 3694432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of furosemide after oral administration to horses.
    Johansson AM; Gardner SY; Levine JF; Papich MG; Lafevers DH; Goldman RB; Sheets MK; Atkins CE
    J Vet Intern Med; 2004; 18(5):739-43. PubMed ID: 15515593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics and pharmacodynamics of furosemide in anesthetized dogs with normal and experimentally decreased renal function.
    Miyazaki H; Hirai J; Taneike T
    Nihon Juigaku Zasshi; 1990 Apr; 52(2):265-73. PubMed ID: 2348592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.